Tudor Investment Corp
FOMX

Tudor Investment Corp’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Tudor Investment Corp’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,000
Closed -$139K – 1711
2016
Q3 		$139K Buy
+15,000
New +$125K ﹤0.01% 1310
2015
Q3 		– Sell
-36,411
Closed -$373K – 1833
2015
Q2 		$373K Buy
+36,411
New +$402K 0.01% 969

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Tudor Investment Corp's FOMX Position: Q4 2016 in Review

Tudor Investment Corp sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2016, closing a stake of 15,000 shares — an estimated $139K sold.

Tudor Investment Corp first reported a position in FOMX in Q2 2015 and held it in 2 quarters. The position peaked at $373K in Q2 2015. 64 funds tracked by Wall St. Rank hold FOMX as of Q4 2016.

  • Tudor Investment Corp reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • Tudor Investment Corp sold 15,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2016, an estimated $139K.
  • Tudor Investment Corp first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 2 quarters.
  • Tudor Investment Corp's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $373K in Q2 2015.
  • 64 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2016.

Based on Tudor Investment Corp's 13F filing for Q4 2016, filed 14 Feb 2017.